3 Growth Stocks Under $20 With Hard Catalyst Dates Ahead
Almonty Industries, Kopin and Cullinan Therapeutics trade under $20, and each faces a near-term catalyst: China tungsten curbs, CES and a February FDA decision.
MarketBeat ·